Frontlight ResearchEarly access
Type 2 diabetes trials in China
154 of 193 trials · From ClinicalTrials.gov, checked 17 November 2026. Ask the study team whether a trial fits you.
- Phase 3Not yet taking people in ChinaA Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus
- Where
- Beijing, Cangzhou, Changchun, Changsha, Chengdu, Danyang, Ganzhou, Guiyang, Hengshui, Huizhou, Lanzhou, Panjin, Qiqihar, Shanghai, Suzhou, Xiamen, Xianyang, Zigong
- Age
- 18 years and over
- People
- 2,500 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07784725 · EU 2025-523379-41-00 - No phaseTaking peopleAcupuncture Plus Mecobalamin for Diabetic Cardiac Autonomic Neuropathy
- Where
- Nanjing
- Age
- 18 years to 70 years
- People
- 60
- Run by
- The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
See details and how to joinNCT07907536 - Phase 3Not yet taking people in ChinaA Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
- Where
- Beijing, Cangzhou, Changchun, Chengdu, Danyang, Ganzhou, Guangzhou, Huizhou, Huzhou, Lanzhou, Nanjing, Panjin, Suzhou, Xianyang
- Age
- 18 years and over
- People
- 1,500 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07784270 - Phase 4Taking peopleA Research Study Looking at Kidney and Heart Health in Adults With Type 2 Diabetes and Chronic Kidney Disease Treated With Semaglutide in China
- Where
- Anyang, Baotou, Beijing, Changchun, Changzhou, Chengdu, Dalian, Fuyang, Huizhou, Jinan, Lanzhou, Linhai, Nanjing, Ningbo, Panjin, Pingxiang, Shanghai, Shantou, Shijiazhuang, Siping, Xining, Yibin, Yichang, Zhenjiang
- Age
- 18 years and over
- People
- 300
- Run by
- Novo Nordisk A/S
See details and how to joinNCT07900438 - Phase 3Taking peopleA Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus
- Where
- Changsha, Hefei, Huai'an, Langfang, Liangyugang, Luoyang, Nanjing, Nanyang, Pinggu, Pingxiang, Shijiazhuang, Tianjin, Yueyang
- Age
- 18 years and over
- People
- 1,200 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07662213 · EU 2025-523933-24-00 - No phaseNot yet taking people in ChinaPreventive Effectiveness of Primary Care Physician-led CGM-supported Comprehensive Intervention on Cardio-metabolic-immune Diseases in Community Patients With Type 2 Diabetes (Community Diabetes Control Project)
- Where
- Changsha
- Age
- 18 years to 80 years
- People
- 15,400
- Run by
- Xiangya Hospital of Central South University
See details and how to joinNCT07885904 - Phase 3Taking peopleA Master Protocol to Investigate Efficacy and Safety of Elecoglipron in Participants With Obesity or Overweight With or Without T2DM
- Where
- Binzhou, Chengdu, Deyang, Ganzhou, Guangzhou, Haikou, Hangzhou, Huaian, Huzhou, Jinan, Jinzhou, Kunming, Lanzhou, Linhai, Liuzhou, Luoyang, Nanchang, Nanjing, Nantong, Ningbo, Panjin, Pingxiang, Qingdao, Shanghai, Shenyang, Shenzhen, Siping, Suining, Suzhou, Ürümqi, Wanzhou, Wenzhou, Wuhan, Wuxi, Xiangyang, Xuancheng, Yibin, Yichang, Zhengzhou, Zhenjiang, Zunyi
- Age
- 18 years and over
- People
- 4,500 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07667803 - Phase 3Taking peopleA Study of BGM0504 in Early T2DM With Obesity
- Where
- Nanjing
- Age
- 18 years to 75 years
- People
- 372
- Run by
- BrightGene Bio-Medical Technology Co., Ltd.
See details and how to joinNCT07743983 - Phase 2Not yet taking people in ChinaA Study of VCT220 Tablets in Adults With Type 2 Diabetes and Inadequate Blood Glucose Control
- Where
- Beijing
- Age
- 18 years to 65 years
- People
- 120
- Run by
- Vincentage Pharma Co., Ltd
See details and how to joinNCT07872436 - Early phase 1Taking peopleEfficacy and Safety of Sanggua Tablets in the Treatment of Patients With Impaired Glucose Tolerance and Mild Type 2 Diabetes
- Where
- Wuhan
- Age
- 18 years to 70 years
- People
- 84
- Run by
- Tongji Hospital
See details and how to joinNCT06964620 - Phase 2Not yet taking people in ChinaA Study of HRS-4729 Injection in Participants With Type 2 Diabetes
- Where
- Tianjin, Wuhan
- Age
- 18 years to 65 years
- People
- 240
- Run by
- Fujian Shengdi Pharmaceutical Co., Ltd.
See details and how to joinNCT07843862 - Phase 1Not yet taking people in ChinaA Study on the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HRS-1596 Tablets in Healthy Participants With a Single Dose and in Obese Participants With Multiple Doses
- Where
- Jinan
- Age
- 18 years to 55 years
- People
- 122
- Run by
- Fujian Shengdi Pharmaceutical Co., Ltd.
See details and how to joinNCT07841860 - Phase 3Taking peopleA Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes
- Where
- Beijing, Chengdu, Guangzhou, Hefei, Jinan, Luoyang Shi, Nanchang, Nanjing, Shanghai
- Age
- 18 years and over
- People
- 1,980 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07321886 · EU 2025-523657-34-00 - No phaseNot yet taking people in ChinaA Multicenter Randomized Double-Blind Trial of Chrocare CDSS for Integrated Management of Type 2 Diabetes
- Where
- Shanghai
- Age
- 18 years and over
- People
- 1,200
- Run by
- Shanghai Jiao Tong University School of Medicine
See details and how to joinNCT07833228 - No phaseTaking peopleThe Cognitive Protective Effect of VR-based Cognitive Training in Type 2 Diabetes Patients With Mild Cognitive Impairment
- Where
- Nanjing
- Age
- 45 years to 80 years
- People
- 40
- Run by
- The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
See details and how to joinNCT07650318 - Phase 1Taking peopleA Single-Dose Pharmacokinetic Study of HRS-4729 Injection in Healthy Participants and Patients With Renal Impairment
- Where
- Chengdu
- Age
- 18 years to 65 years
- People
- 32
- Run by
- Fujian Shengdi Pharmaceutical Co., Ltd.
See details and how to joinNCT07807059 - Phase 3Taking peoplePhase III Study of UBT251 Injection in Patients With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Diet and Exercise Alone(UNIGUIDE-1)
- Where
- Changsha
- Age
- 18 years to 75 years
- People
- 360
- Run by
- The United Bio-Technology (Hengqin) Co., Ltd.
See details and how to joinNCT07659574 - Phase 4Taking peopleIntervention for High-normal Blood Pressure in Adults With Type 2 Diabetes
- Where
- Guangzhou
- Age
- 45 years to 79 years
- People
- 11,414
- Run by
- XueQing Yu
See details and how to joinNCT03264352 - Phase 3Taking peoplePhase III Study of UBT251 Injection in Patients With Type 2 Diabetes With Inadequate Glycemic Control on Metformin ± Sulfonylurea/SGLT2 Inhibitor Therapy (UNIGUIDE-2)
- Where
- Shanghai
- Age
- 18 years to 75 years
- People
- 956
- Run by
- The United Bio-Technology (Hengqin) Co., Ltd.
See details and how to joinNCT07653477 - Phase 4Taking peopleFingolimod for Type 2 Diabetes Mellitus
- Where
- Shenyang
- Age
- 18 years to 70 years
- People
- 40
- Run by
- General Hospital of Shenyang Military Region
See details and how to joinNCT05307731 - Phase 2Taking peoplePhase 2 Clinical Study of MWN109 Tablets in Participants With Type 2 Diabetes Mellitus
- Where
- Beijing
- Age
- 18 years to 75 years
- People
- 240
- Run by
- Shanghai Minwei Biotechnology Co., Ltd
See details and how to joinNCT07801820 - No phaseTaking peopleEffect of Continuous Glucose Monitoring System on Glycemic Control in Non-insulin-Treated Elderly People With Type 2 Diabetes
- Where
- Shenzhen
- Age
- 60 years and over
- People
- 148
- Run by
- Shanghai 6th People's Hospital
See details and how to joinNCT07007676 - Phase 1Not yet taking people in ChinaA Clinical Study to Evaluate the Safety and Efficacy of RGB-5088 in Patients With Type 2 Diabetes Mellitus
- Where
- Beijing
- Age
- 18 years to 65 years
- People
- 10
- Run by
- Hangzhou Reprogenix Bioscience, Inc
See details and how to joinNCT07794254 - Phase 1Taking peoplePhase 1 Clinical Study of MWN105 Injection in Participants With Overweight or Obesity
- Where
- Kunming
- Age
- 18 years to 50 years
- People
- 36
- Run by
- Shanghai Minwei Biotechnology Co., Ltd
See details and how to joinNCT07803809 - Phase 3Taking peopleMazdutide in Type 2 Diabetes With Early-Stage Cognitive Impairment (LIGHT-COG Study)
- Where
- Changsha, Changzhou, Dalian, Nanjing, Shanghai
- Age
- 50 years to 75 years
- People
- 420
- Run by
- The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
See details and how to joinNCT07083154